Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8675643.
- Also identified by PMC identifier 185983.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have studied the effect of chemotherapy on the level of a particular kind of genetic instability in patients with Hodgkin's disease. The particular type of genetic instability assayed is exemplified by trans-rearrangements between two (rather than within one) T cell antigen receptor. 16 patients were studied during their course of treatment. Presentation samples were available for 13 of these patients; 9 of them showed an increase in the level of trans-rearrangements during their exposure to chemotherapeutic agents (P < 0.043). All patients for whom posttherapy samples were available (10 out of 16) showed a return to baseline levels of trans-rearrangements 1-5 mo after completion of therapy (P < 0.03). Thus, this assay appears to be a marker for the "destabilizing" effects of certain chemotherapeutic agents.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Gene Rearrangement, T-Lymphocyte
- Hodgkin Disease